This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berthomme, H.
Right arrow Articles by Feldman, L. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berthomme, H.
Right arrow Articles by Feldman, L. T.

 Previous Article  |  Next Article 

Journal of Virology, April 2000, p. 3613-3622, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Evidence for a Bidirectional Element Located Downstream from the Herpes Simplex Virus Type 1 Latency-Associated Promoter That Increases Its Activity during Latency

Herve Berthomme,1,dagger James Lokensgard,1 Li Yang,2 Todd Margolis,2 and Lawrence T. Feldman1,*

Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, California 90095,1 and F. I. Proctor Foundation and Department of Ophthalmology, University of California at San Francisco, San Francisco, California 941432

Received 16 November 1999/Accepted 12 January 2000

Herpes simplex virus type 1 (HSV-1) latent infection in vivo is characterized by the constitutive expression of the latency-associated transcripts (LAT), which originate from the LAT promoter (LAP). In an attempt to determine the functional parts of LAP, we previously demonstrated that viruses harboring a DNA fragment 3' of the LAT promoter itself were able to maintain detectable promoter expression throughout latency whereas viruses not containing this element could not (J. R. Lokensgard, H. Berthomme, and L. T. Feldman, J. Virol. 71:6714-6719, 1997). This element was therefore called a long-term expression element (LTE). To further study the role of the LTE, we constructed plasmids containing a DNA fragment encompassing the LTE inserted into a synthetic intron between the reporter lacZ gene and either the LAT or the HSV-1 thymidine kinase promoter. Transient-expression experiments with both neuronal and nonneuronal cell lines showed that the LTE locus has an enhancer activity that does not activate the cytomegalovirus enhancer but does activate the promoters such as the LAT promoter and the thymidine kinase promoter. The enhancement of these two promoters occurs in both neuronal and nonneuronal cell lines. Recombinant viruses containing enhancer constructs were constructed, and these demonstrated that the enhancer functioned when present in the context of the viral DNA, both for in vitro infections of cells in culture and for in vivo infections of neurons in mouse dorsal root ganglia. In the infections of mouse dorsal root ganglia, there was a very high level of promoter activity in neurons infected with viruses bearing the LAT promoter-enhancer, but this decreased after the first 2 or 3 weeks. By 18 days postinfection, neurons harboring latent virus without the enhancer showed no beta -galactosidase (beta -gal) staining whereas those harboring latent virus containing the enhancer continued to show beta -gal staining for long periods, extending to at least 6 months postinfection, the longest time examined.


* Corresponding author. Mailing address: Department of Microbiology and Immunology, 43-169CHS, UCLA School of Medicine, Los Angeles, CA 90095-1405. Phone: (310) 206-1014. Fax: (310) 206-3865. E-mail: lfeldman{at}microimmun.medsch.ucla.edu.

dagger Present address: Centre de Genetique Moleculaire et Cellulaire, UMR5534 CNRS, Université Claude Bernard Lyon 1, Villeurbanne Cedex, France.


Journal of Virology, April 2000, p. 3613-3622, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bertke, A. S., Patel, A., Imai, Y., Apakupakul, K., Margolis, T. P., Krause, P. R. (2009). Latency-Associated Transcript (LAT) Exon 1 Controls Herpes Simplex Virus Species-Specific Phenotypes: Reactivation in the Guinea Pig Genital Model and Neuron Subtype-Specific Latent Expression of LAT. J. Virol. 83: 10007-10015 [Abstract] [Full Text]  
  • Imai, Y., Apakupakul, K., Krause, P. R., Halford, W. P., Margolis, T. P. (2009). Investigation of the Mechanism by Which Herpes Simplex Virus Type 1 LAT Sequences Modulate Preferential Establishment of Latent Infection in Mouse Trigeminal Ganglia. J. Virol. 83: 7873-7882 [Abstract] [Full Text]  
  • Cliffe, A. R., Garber, D. A., Knipe, D. M. (2009). Transcription of the Herpes Simplex Virus Latency-Associated Transcript Promotes the Formation of Facultative Heterochromatin on Lytic Promoters. J. Virol. 83: 8182-8190 [Abstract] [Full Text]  
  • Neumann, D. M., Bhattacharjee, P. S., Giordani, N. V., Bloom, D. C., Hill, J. M. (2007). In Vivo Changes in the Patterns of Chromatin Structure Associated with the Latent Herpes Simplex Virus Type 1 Genome in Mouse Trigeminal Ganglia Can Be Detected at Early Times after Butyrate Treatment. J. Virol. 81: 13248-13253 [Abstract] [Full Text]  
  • Bertke, A. S., Patel, A., Krause, P. R. (2007). Herpes Simplex Virus Latency-Associated Transcript Sequence Downstream of the Promoter Influences Type-Specific Reactivation and Viral Neurotropism. J. Virol. 81: 6605-6613 [Abstract] [Full Text]  
  • Amelio, A. L., Giordani, N. V., Kubat, N. J., O'Neil, J. E., Bloom, D. C. (2006). Deacetylation of the Herpes Simplex Virus Type 1 Latency-Associated Transcript (LAT) Enhancer and a Decrease in LAT Abundance Precede an Increase in ICP0 Transcriptional Permissiveness at Early Times Postexplant. J. Virol. 80: 2063-2068 [Abstract] [Full Text]  
  • Kubat, N. J., Amelio, A. L., Giordani, N. V., Bloom, D. C. (2004). The Herpes Simplex Virus Type 1 Latency-Associated Transcript (LAT) Enhancer/rcr Is Hyperacetylated during Latency Independently of LAT Transcription. J. Virol. 78: 12508-12518 [Abstract] [Full Text]  
  • Theopold, C., Yao, F., Eriksson, E. (2004). Gene Therapy in the Treatment of Lower Extremity Wounds. INT J LOW EXTREM WOUNDS 3: 69-79 [Abstract]  
  • Jones, C. (2003). Herpes Simplex Virus Type 1 and Bovine Herpesvirus 1 Latency. Clin. Microbiol. Rev. 16: 79-95 [Abstract] [Full Text]  
  • Perng, G.-C., Maguen, B., Jin, L., Mott, K. R., Kurylo, J., BenMohamed, L., Yukht, A., Osorio, N., Nesburn, A. B., Henderson, G., Inman, M., Jones, C., Wechsler, S. L. (2002). A Novel Herpes Simplex Virus Type 1 Transcript (AL-RNA) Antisense to the 5' End of the Latency-Associated Transcript Produces a Protein in Infected Rabbits. J. Virol. 76: 8003-8010 [Abstract] [Full Text]  
  • Lilley, C. E., Groutsi, F., Han, Z., Palmer, J. A., Anderson, P. N., Latchman, D. S., Coffin, R. S. (2001). Multiple Immediate-Early Gene-Deficient Herpes Simplex Virus Vectors Allowing Efficient Gene Delivery to Neurons in Culture and Widespread Gene Delivery to the Central Nervous System In Vivo. J. Virol. 75: 4343-4356 [Abstract] [Full Text]  
  • Berthomme, H., Thomas, J., Texier, P., Epstein, A., Feldman, L. T. (2001). Enhancer and Long-Term Expression Functions of Herpes Simplex Virus Type 1 Latency-Associated Promoter Are both Located in the Same Region. J. Virol. 75: 4386-4393 [Abstract] [Full Text]